Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
10.78 USD | +2.76% | -6.83% | -12.00% |
Chart calendar KalVista Pharmaceuticals, Inc.
Upcoming events on KalVista Pharmaceuticals, Inc.
Past events on KalVista Pharmaceuticals, Inc.
2024-04-10 10:15 am | Needham Healthcare Conference |
2024-03-12 09:20 am | Leerink Partners Global Biopharma Conference |
2024-03-11 06:30 am | Q3 2024 Earnings Release |
2024-02-25 09:45 am | American Academy of Allergy, Asthma & Immunology Meeting |
2024-02-24 09:45 am | American Academy of Allergy, Asthma & Immunology Meeting |
2024-02-13 08:30 am | KONFIDENT Phase 3 Trial Results Call |
2023-12-07 06:30 am | Q2 2024 Earnings Release |
2023-11-16 04:30 am | Jefferies London Healthcare Conference |
2023-11-14 03:00 pm | Stifel Healthcare Conference |
2023-11-12 03:20 pm | American College of Allergy Asthma & Immunology Scientific Meeting - Poster No #P092 |
2023-11-12 03:20 pm | American College of Allergy Asthma & Immunology Scientific Meeting - Poster No #P070 |
2023-11-12 03:05 pm | American College of Allergy Asthma & Immunology Scientific Meeting - Poster No #P069 |
2023-11-11 02:50 pm | American College of Allergy Asthma & Immunology Scientific Meeting - Poster No #P085 |
2023-11-10 08:15 pm | American College of Allergy Asthma & Immunology Scientific Meeting - Poster No #P059 |
2023-11-10 07:30 pm | American College of Allergy Asthma & Immunology Scientific Meeting - Poster No #P078 |
2023-09-27 04:10 pm | Cantor Global Healthcare Conference |
2023-09-26 09:30 am | Annual General Meeting |
2023-09-07 06:30 am | Q1 2024 Earnings Release |
2023-09-01 01:15 pm | HAEi Regional Conference |
2023-07-10 | SVB Securities Therapeutics Forum |
Annual results
Fiscal Period | April | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|---|---|
Net sales Million USD | Released Forecast Spread | 16,1 17,2 -6.44% | 12,7 10,5 20.43% | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 |
EBITDA | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 |
EBIT Million USD | Released Forecast Spread | -29,8 -25,9 -15.32% | -40,5 -46,0 11.97% | -57,9 -54,6 -6.12% | -96,6 -98,2 1.59% | -111 -107 -3.28% | -126 |
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -20,7 -29,6 30.09% | -29,2 -35,4 17.49% | -46,2 -43,6 -5.95% | -82,3 -84,4 2.44% | -92,9 -93,3 0.41% | -114 |
Net income Million USD | Released Forecast Spread | -20,8 -29,6 29.68% | -29,1 -35,1 16.98% | -46,2 -43,7 -5.94% | -82,3 -84,6 2.69% | -92,9 -92,7 -0.26% | -114 |
EPS USD | Released Forecast Spread | -1,38 -2,11 34.6% | -1,64 -1,94 15.35% | -2,42 -2,30 -5.22% | -3,36 -3,45 2.67% | -3,33 -3,44 3.25% | -3,04 |
Announcement Date | 15/07/19 | 29/06/20 | 13/07/21 | 07/07/22 | 07/07/23 | - |
Quarterly results
Fiscal Period | April | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 | 2025 Q2 | 2025 Q3 | 2025 Q4 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net sales Million USD | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 | 0,00 | 1,21 | 1,81 | 7,27 |
EBIT Million USD | Released Forecast Spread | -26,7 -25,3 -5.5% | -26,8 -28,4 5.49% | -26,3 -27,7 4.87% | -25,9 -27,7 6.69% | -26,9 -28,2 4.6% | -31,7 -28,2 -12.45% | -29,1 -31,2 6.73% | -29,7 -29,8 0.33% | -33,2 -32,0 -3.58% | -34,1 | -34,1 | -34,0 | -34,5 | -28,0 |
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -22,5 -23,5 4.56% | -24,1 -26,7 9.76% | -23,0 -24,2 4.77% | -22,3 -25,9 13.92% | -21,3 -26,2 18.84% | -26,3 -26,7 1.43% | -25,3 -29,0 12.83% | -27,7 -27,1 -1.99% | -29,0 -30,5 4.79% | -31,6 | -31,3 | -31,3 | -31,9 | -25,5 |
Net income Million USD | Released Forecast Spread | -22,5 -22,3 -0.96% | -24,1 -26,8 10.09% | -23,0 -24,2 4.77% | -22,3 -26,1 14.68% | -21,3 -26,3 18.99% | -26,3 -26,1 -0.94% | -25,3 -29,0 12.83% | -27,7 -27,1 -1.99% | -29,0 -30,4 4.43% | -32,1 | -31,4 | -31,4 | -31,8 | -27,6 |
EPS USD | Released Forecast Spread | -0,92 -0,90 -2.6% | -0,98 -1,09 9.82% | -0,94 -0,97 3.09% | -0,90 -1,05 14.29% | -0,75 -1,00 25% | -0,77 -0,87 11.29% | -0,74 -0,84 11.9% | -0,80 -0,78 -2.13% | -0,84 -0,79 -6.55% | -0,72 | -0,67 | -0,67 | -0,67 | -0,57 |
Announcement Date | 10/03/22 | 07/07/22 | 08/09/22 | 08/12/22 | 09/03/23 | 07/07/23 | 07/09/23 | 07/12/23 | 11/03/24 | - | - | - | - | - |
Past sector events for KalVista Pharmaceuticals, Inc.
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- KALV Stock
- Calendar KalVista Pharmaceuticals, Inc.